cardiometabolic care
Roche’s Top Three Ambition in Obesity Not Dependent on a Single Megablockbuster
Roche; obesity strategy; ecosystem approach; pharmaceuticals; diagnostics; digital health; cardiometabolic care; portfolio diversification; weight-loss drugs